927 related articles for article (PubMed ID: 6887866)
1. Steroid receptor forms and their interaction with cytoplasmic modulators.
Sato B; Nishizawa Y; Maeda Y; Noma K; Honma T; Matsumoto K
J Steroid Biochem; 1983 Jul; 19(1A):315-21. PubMed ID: 6887866
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a unique nuclear estrogen-binding component in an estrogen-responsive mouse Leydig cell tumor.
Maeda Y; Sato B; Noma K; Kishimoto S; Koizumi K; Aono T; Matsumoto K
Cancer Res; 1983 Sep; 43(9):4091-7. PubMed ID: 6871850
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of activation of steroid receptors: involvement of low molecular weight inhibitor in activation of androgen, glucocorticoid, and estrogen receptor systems.
Sato B; Noma K; Nishizawa Y; Nakao K; Matsumoto K; Yamamura Y
Endocrinology; 1980 Apr; 106(4):1142-8. PubMed ID: 7358030
[No Abstract] [Full Text] [Related]
4. Effect of molybdate on activation and stabilization of steroid receptors.
Noma K; Nakao K; Sato B; Nishizawa Y; Matsumoto K; Yamamura Y
Endocrinology; 1980 Oct; 107(4):1205-11. PubMed ID: 7408768
[TBL] [Abstract][Full Text] [Related]
5. A modulator which converts activated estrogen receptor to a biologically inactive aggregated form.
Nishizawa Y; Maeda Y; Noma K; Sato B; Matsumoto K; Yamamura Y
Endocrinology; 1981 Nov; 109(5):1463-72. PubMed ID: 6795027
[TBL] [Abstract][Full Text] [Related]
6. Nuclear retention of all steroid hormone receptor classes in the hamster renal carcinoma.
Li JJ; Li SA; Cuthbertson TL
Cancer Res; 1979 Jul; 39(7 Pt 1):2647-51. PubMed ID: 445467
[TBL] [Abstract][Full Text] [Related]
7. [Comparative study of the interaction between different forms of estrogen receptors and cell nuclei].
Mataradze GD; Gontar' EV; Kondrat'ev IaIu; Rozen VB
Biokhimiia; 1982 May; 47(5):869-78. PubMed ID: 7093387
[TBL] [Abstract][Full Text] [Related]
8. Basal and estrogen-stimulated hormone receptor profiles in four R3327 rat prostatic carcinoma sublines in relation to histopathology and androgen sensitivity.
Mobbs BG; Johnson IE
Cancer Res; 1988 Jun; 48(11):3077-83. PubMed ID: 3259159
[TBL] [Abstract][Full Text] [Related]
9. Elevated concentration of a dexamethasone-receptor translocation inhibitor in Novikoff hepatoma cells.
Liu SL; Webb TE
Cancer Res; 1977 Jun; 37(6):1763-7. PubMed ID: 192460
[TBL] [Abstract][Full Text] [Related]
10. beta-Diethylaminoethyl-2, 2-diphenylpentanoate (SKF 525-A)-mediated translocation of uterine estrogen receptor from the cytosolic to the nuclear compartment in isolated rat uteri.
Bulger WH; Kupfer D
Mol Pharmacol; 1982 May; 21(3):533-7. PubMed ID: 7110114
[TBL] [Abstract][Full Text] [Related]
11. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells.
Reiner GC; Katzenellenbogen BS; Bindal RD; Katzenellenbogen JA
Cancer Res; 1984 Jun; 44(6):2302-8. PubMed ID: 6547074
[TBL] [Abstract][Full Text] [Related]
12. The testicular estrogen receptor system in two strains of mice differing in susceptibility to estrogen-induced Leydig cell tumors.
Sato B; Spomer W; Huseby RA; Samuels LT
Endocrinology; 1979 Mar; 104(3):822-31. PubMed ID: 436739
[TBL] [Abstract][Full Text] [Related]
13. Androgen- and estrogen-receptor content in spontaneous and experimentally induced canine prostatic hyperplasia.
Trachtenberg J; Hicks LL; Walsh PC
J Clin Invest; 1980 May; 65(5):1051-9. PubMed ID: 6154062
[TBL] [Abstract][Full Text] [Related]
14. Steroid hormone receptor characterization of several histologic variants of a rat prostatic adenocarcinoma.
Markland FS; Chopp RT; Cosgrove MD; Howard EB
J Supramol Struct; 1978; 9(4):509-24. PubMed ID: 750763
[TBL] [Abstract][Full Text] [Related]
15. [Cytoplasm to nucleus translocation patterns of different forms of hepatic estrogen receptors].
Mataradze GD; Kondrat'ev IaIu; Gontar' EV; Smirnov AN; Rozen VB
Biull Eksp Biol Med; 1981 May; 91(5):568-71. PubMed ID: 7260387
[TBL] [Abstract][Full Text] [Related]
16. [Interaction of dexamethasone-receptor complexes with rat liver nuclei and DNAs].
Romanov GA; Sokolova NA; Rozen VB; Vaniushin BF
Biokhimiia; 1976 Dec; 41(12):2140-9. PubMed ID: 1022278
[TBL] [Abstract][Full Text] [Related]
17. [Activation of glucocorticoid cytoreceptors in rat heart].
Seleznev IuM; Danilov SM; Volkova NG; Medvedeva LA
Biokhimiia; 1979 Feb; 44(2):245-51. PubMed ID: 435564
[TBL] [Abstract][Full Text] [Related]
18. The nuclear estrogen receptor R-II of the goat uterus: distinct possibility that the R-II is the deglycosylated form of the nonactivated estrogen receptor (naER).
Karthikeyan N; Thampan RV
Arch Biochem Biophys; 1995 Aug; 321(2):442-52. PubMed ID: 7544097
[TBL] [Abstract][Full Text] [Related]
19. Interactions of putative estrogens with the intracellular receptor complex in mouse Leydig cells: relationship to preneoplastic hyperplasia.
Juriansz RL; Huseby RA; Wilcox RB
Cancer Res; 1988 Jan; 48(1):14-8. PubMed ID: 3334987
[TBL] [Abstract][Full Text] [Related]
20. Partial characterization of protease(s) in human breast cancer cytosols that can degrade estrogen and progesterone receptors selectively.
Maeda K; Tsuzimura T; Nomura Y; Sato B; Matsumoto K
Cancer Res; 1984 Mar; 44(3):996-1001. PubMed ID: 6362861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
